Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

James Kihara

Principal Accounting Officer at Acadia Pharmaceuticals Inc (ACAD)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $603K

Reported trades

Filed Stock Type Shares Price Value Since
Jun 29SEC ACADAcadia Pharmaceuticals Inc Sell Plan 11,42113,088 held (−47%) $26.08 $298K -24.2%
May 27SEC ACADAcadia Pharmaceuticals Inc Sell 5,40124,509 held (−18%) $21.18 $114K -6.6%
May 5SEC ACADAcadia Pharmaceuticals Inc Sell Plan 1,33229,129 held (−4%) $21.79 $29K -9.2%
Apr 7SEC ACADAcadia Pharmaceuticals Inc Sell Plan 1,03027,865 held (−4%) $22.20 $23K -10.9%
Mar 26SEC ACADAcadia Pharmaceuticals Inc Sell Plan 83325,852 held (−3%) $21.47 $18K -7.9%
Mar 26SEC ACADAcadia Pharmaceuticals Inc Sell Plan 1,09726,897 held (−4%) $21.65 $24K -8.6%
Mar 26SEC ACADAcadia Pharmaceuticals Inc Sell Plan 1226,885 held (−0%) $21.73 $261 -9.0%
Nov 19SEC ACADAcadia Pharmaceuticals Inc Sell Plan 4,08425,058 held (−14%) $23.69 $97K -16.5%
  • Sell

    Principal Accounting Officer James Kihara sold $298K of ACAD at $26.08 — cuts the stake by 47%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Principal Accounting Officer James Kihara sold $29K of ACAD at $21.79 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Principal Accounting Officer James Kihara sold $23K of ACAD at $22.20 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Principal Accounting Officer James Kihara sold $18K of ACAD at $21.47 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Principal Accounting Officer James Kihara sold $24K of ACAD at $21.65 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Principal Accounting Officer James Kihara sold $261 of ACAD at $21.73 — pre-scheduled 10b5-1 plan sale.